Author Question: The patient was unable to achieve an acceptable blood pressure with just lifestyle changes so in ... (Read 76 times)

burchfield96 · **on:** Jul 23, 2018

The patient was unable to achieve an acceptable blood pressure with just lifestyle changes so in stage 2 of the stepped-care management of hypertension plan, an angiotensin-converting enzyme inhibitor was ordered.

In step 3, when inadequate response was obtained from step 2, the nurse anticipates the provider will order what? A) A diuretic
B) A beta-blocker
C) A calcium channel blocker
D) A vasodilator

Question 2

A patient with acute myeloblastic leukemia is taking doxorubicin. What medication, if ordered, would the nurse recognize as a cardioprotective drug used in combination with doxorubicin?

A) Dexrazoxane (Zinecard)
B) Ixabepilone (Ixempra)
C) Teniposide (Vumon)
D) Vinblastine (Velban)

jazzlynnnnn · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

A
Feedback:
In step 3, another drug will be added for combined effect. However, fixed-combination drugs should only be used when the patient has been stabilized on each drug separately. A diuretic would be added before adding another class of medication unless the first drug was a diuretic. Vasodilators are generally used only in hypertensive emergencies.

Answer to Question 2

A
Feedback:
Dexrazoxane is a powerful chelating agent that is a cardioprotective drug that interferes with the cardiotoxic effects of doxorubicin. Ixabepilone (Ixempra) is given in combination with capecitabine for the treatment of patients with metastatic or locally advanced breast cancer. Teniposide is given in combination with other drugs for induction therapy in childhood acute lymphoblastic leukemia. Vinblastine is given in combination with other medications as part of the treatment for advanced testicular germ cell cancer.